Status
Conditions
About
This is a single arm, single centre imaging study which will be offered to all consecutive, eligible patients receiving radical chemoradiation therapy (CRT) for anal cancer within Oxford University Hospitals.
Investigations
Study Design: Observational
Target Population: Patients undergoing radical CRT for anal cancer in Oxford University Hospitals National Health Service (NHS) Trust.
Duration on study: Patients should be on study for a maximum of 5 months.
Patient care post-trial: Follow up as per local standard.
No. of Study Site(s): Single Centre, United Kingdon (UK)
End of study: Last Patient, last assessment of response. Patients should be on study for a maximum of 5 months.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Additional criteria for optional oxygen breathing procedure:
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal